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Echinococcus granulosus a parasite characterized with intra-species variability and genetic studies show 
existence of 10 genotypes (G1-G10). Host specificity and different susceptibility to intermediate hosts 
has also been demonstrated. Better understanding of this parasitosis can assist in designing appropriate 
control and preventive measures and its management based on strain-molecular peculiarity. Thus, the 
necessity for identification and characterization of all strains. A total of 96 hydatid cysts from which 
either protoscolces or germinal membranes were extracted followed by DNA extraction and then, 
amplification by random amplification of polymorphic DNA (RAPD). The RAPD products with distinctive 
bands were cloned in pGEMT-Easy vector and recombinant DNA subjected to sequencing. Twelve 
oligonucleotides primers were designed from recombinant DNA sequences and strains-specific PCR 
were conducted. The PRC products amplified by primers P1F2R2 (Ta=66°C, 35 cycles) and P1F1R1TX-
PCRs (Ta = 66°C, 35 cycles) showed specie-specificity. Analysis of the DNA sequences showed 
homologies to some important molecules like laminin-binding protein and glutathione transferase. 
Notwithstanding that the present study indicates partial success on attaining distinctive strain-specific 
DNA sequences, the resultant polymerase chain reaction (PCR) products were not strain-discriminatory. 
It is speculated that incorporation of more restriction endonucleases and well-adjusted reaction 
conditions strain-distinctive PCR-restriction fragment lenght polymorphism (RFLP) can be designed. 
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zoonotic infection caused by cestodes of the genus 
Echinococcus. The genus Echinococcus contains four 
recognized species: Echinococcus granulosus, 
Echinococcus multilocularis, Echinococcus vogel and 
Echinococcus oligarthrus. These are readily distinguish-
able at both adult and larval stages by standard 
taxonomic criteria including host preferences, epide-
miological, biological development and morphological 
characteristics (Dubinský et al., 1998; Karimi and 
Dianatpour, 2008). Several strains of E. granulosus have 
been proposed based upon those criteria (Siles-Lucas et 
al., 1996; M’radi et al., 2010). Human parasitism is mainly 
due to cystic form of E. granulosus,   which   also   affects   
angulated    domestic   animals   such   as  cattle,  sheep, 




goats and horses.  
The parasite’s life cycle involves two hosts including 
definitive hosts (dogs or other carnivores) and inter-
mediate hosts (the angulated domestic animals, human 
inclusive). In definitive hosts (DHs), damage caused by 
the adult worm is limited to anchorage site in the intestine 
of the DH, which causes necrosis to cells adhering to the 
parasite’s suckers or rupture of Lieberkhun crypts, 
releasing host cells in the crypt. Massive infestations can 
provoke excessive production of mucus, but generally, 
does not tend to produce damage or important cellular 
reactions against the parasite (Siles-Lucas et al., 1996). 
In intermediate hosts (IHs), the parasite in form of 
metacestode (hydatid cyst-HC) is characterized by its 
typical three membranous layers namely, adventitious, 
laminar and germinal membranes. From the germinal 
membrane, brood capsules develop, each containing one 
or several invaginated heads (protoscoleces-PPs) that 
can develop into the adult tapeworm upon ingestion by 
the DH (Macpherson, 1983).   
In order to kill the living germinal membrane (GM) and 
its contents-protoescoleces within the HC, the anthe-
lminthic drugs must penetrate all the three barrier-layers, 
hence, comes the variability in efficacy of chemo-
therapeutic agents (Taylor et al., 1989; Teggi et al., 1993; 
Hildreth and Granholm, 2003). Thus, there is a pressing 
need of designing an appropriate and effective therapy. 
One of the several possible approaches is by conducting 
thorough genetic and molecular identification and 
characterization of strains, which in turn may lead to 
better understanding of targeted therapy (Duncan, 1997; 
Debouck and Goodfellow, 1999).  
Moreover, E. granulosus is a parasite that shows a 
great intra-species variability all over the world. Genetic 
studies on E. granulosus have been carried out in several 
countries, demonstrating the existence of various strains 
categorized in 10 genotypes (G1-G10):  Firstly, that 
which affects sheep (G1), cows (G2) and humans (G1); 
the second occurs in sheep, goat and human (G1), 
horses (G4), camel (G6), pig (G7), sheep Tasmania (G2) 
and cattle (G5); as well as  buffalo (G3) and cervid (G8)-
(González et al., 2002; Mwambete et al., 2004; M’radi et 
al., 2010). Genotypes G9 and G10 are still under study 
(Lavikainen et al., 2003; Busi et al., 2007; Vural et al., 
2008). Host specificity and different susceptibility with 
regard to IHs has been demonstrated both in in vivo and 
in vitro studies Ponce-Gordo, 1995. Consequently, better 
knowledge on the disease will not only improve human 
health by designing appro-priate measures for its 
management based on involved strains, but also design 
chemotherapeutic agents based on differential molecular 
peculiarity with lesser side effects. Thus, there is a 
necessity to identify and charac-terize of all strains of this 
parasite.  
Various techniques and approaches have been 
employed in studying this variability, naming: Random 





and PCR-RFLP (González et al., 2002; Karimi and 
Dianatpour, 2008). Recently, sequencing of the parasite 
genomic DNA has been adopted (Mwambete et al., 2006. 
The sequencing of the mitochondrial cyto-chrome c 
oxidase subunit 1 (CO1) and NADH dehydro-genase 1 
(ND1) genes have been extensively used as bench 
marks for molecular genetic characterization of parasites 
using these two primers (González et al., 2002; 
Mwambete et al., 2004). 
 
 
MATERIALS AND METHODS 
 
Biological parasite materials 
 
Hydatid cysts were obtained from abattoirs and hospitals in the 
Autonomic Community of Castilla-Leone (Spain) derived from 
sheep, goats, horses, pigs and humans. Parasite materials 
employed comprise of Peyer’s patches (PPs) or GMs obtained from 
the sensory hair cells (HCs) proceeded with aspiration of the fluids 
to reduce the cystic pressure. HCs need to be aseptically con-
served and transported in appropriate containers to avoid 
contaminations.  The obtained materials were stored at 4°C if were 
to be used within short time or at -20°C till further use.  
 
 
Extraction and amplification of DNA 
 
Phenol-chloroform-isoamyl standard procedures were used for the 
extraction of the genomic DNA followed by concentration and 
spectrophotometric quantification at 260 nm (25 Heath, 1997). 
RAPD reactions were conducted in 25 to 30 µl volumes containing 
50 mM MgCl2, 25 mM dNTPs, 1% 20x Taq DNA polymerase buffer, 
25 to 30 ng genomic DNA and 5 units of Taq DNA polymerase 
(Epicentre-Technologies, Spain). The following four primers 
consisting of 10 nucleotides each, were used at final concentration 
of 0.2 µM: 5;-GTT TCG CTC C-3’ (OPB1), 5’-CTG CTG GGA C-3’ 
(OPB10), 5’-CAG CAC CGC A-3’ (OPZ3), 5’-CAA AGG GCG G-3’ 
(OPAD1), and 5’-GGG AAT TCC C-3’ (OPF6). The mixture was 
overlaid with 30 µl mineral oil (Sigma) prior to subjecting to 
thermocycler (GTC-2 Precision-Scientific, USA). 
Conditions of reaction for RAPD were adjusted to: Initial 
denaturization at 94°C for 6 min, followed by 44 cycles at 94°C, 1 
min at 36°C, 2 min at 72°C and final extension of 6 min at 72°C. 
The amplification products were separated in high temperature 
gelification agarose gels (2%) and visualized by ethidium bromide 
staining under UV illumination. These products may be directly 
subjected to sequencing of a distinctive fragment and/or to 
enzymatic digestion by restriction length enzymes/endonucleases.  
 
 
Cloning of RAPD products 
 
Strain-discriminating RAPD amplification products (Figure 1) from 
which 1 ul aliquot was drawn were subjected to cloning process 
using cloning vectors like pGEMT-Easy and thus, obtaining 
recombinants plasmids, which were selected accordingly (Promega, 
2009). Recombinants plasmids were also processed by 
electrophoresis or /and RFLP in order to select DNA fragments of 
different sizes, though this does not guarantee sequences’ 
compositions distinction. A plasmid that produced a single band or 
at least two brighter and wider band was considered to be the ideal 
insert/recombinant DNA. This process also served as means of 
quantifying the recombinants DNA prior to sequencing of the same 
(Duarte and Izquierdo, 1992; Health, 1997).  






Figure 1. RAPD product with distinctive band patterns amplified by OPB1 primer. M, Molecular marker; 1, 




DNA sequencing and design of olygonucleotide primers  
 
The parasite DNA inserts from recombinant plasmids were sequen-
ced by fluorescence-based labelling sequencier ABI–PRISM-377 
(Perkin–Elmer, Germany) which proceeded with comparison of 
DNA sequences using European Molecular Biology Laboratory 
(EMBL) and GenBank databases with other finder partners like the 
genetic computer software (Devereux et al., 1984, Rice et al., 
2000). DNASTAR (England) was largely employed for analysis of 
DNA sequences by the primer select lasergene program and 
design of primers. Several factors were taken into consideration 
prior to selecting a given DNA sequence/fragment as a target for 
primers designing like positioning of the primer within the target 
template, melting temperature (Tm) and length of the fragment 
(mers) and most importantly score of the candidate primers. 
Primers that started with G and/or C or at least the second base 
were G or C; they were selected because of their stability and thus 
reproducibility of their PCR products. However, the G + C content 
ranging from 50 to 55% and Tm > 45°C produced better results 
than those with lower Tm. 
 
 
Conditions of reactions for distinctive RAPD-PCR protocols 
 
The H41F1R1-PCR (Ta = 60 to 66°C, 35 cycles) only amplified 
DNA from parasites of the genus Echninococcus without amplifying 
even the closely related genius of Taenia or other parasites of the 
family Taenidae to which E. granulosus belongs. Similarly, S6F1R1-
PCR (Ta = 66°C, 35 cycles) amplified both isolates of E. granulosus 
and E. multilocularis.  
 
 
Screening for proteins of clinical interests 
 
Prior to nucleotide-proteins alignment, all  DNA  recombinants  were  
checked for vector contaminationusing Basic Local Alignment 
Sequences Tool (BLAST) 2EVEC (Gish and States, 1993). Then, 
all sequenced DNA fragments were compared with already 
available EMBL and GenBank. DNA databases using various online 
software like advanced BLAST-(Gish and States, 1993), 
Washington University BLAST (WU-BLAST), nucleotide-amino acid 
alignment program (NAP) and local alignment program (LAP). The 
latter two programs served for ruling in or out presence of introns 
and frame shifts (Huang and Zhang, 1996; Huang et al., 1997).  
 
 
RESULTS AND DISCUSSION 
 
A total of 96 hydatid cysts from which either PPs or GMs 
were collected and subsequently employed for DNA 
extraction were gotten. Figure 2 shows the OPB1 primer 
RAPD amplified DNA (derived from horse, pig, sheep, 
goat and human) with clear distinctive band patterns 
among them at A(2.0 kb), B (1.5 kb), C(1.0 kb) and D(0.7 
kb), which were later cloned in the pGEMT-Easy vector.  
The cloned RADP products resulted into 23 recombinant 
DNA/inserts that were in turn, primed by DNAStar 
(PrimerSelect) software, 12 potential pairs of olygo-
nucleotide primers were identified by using SeqMan 
program (DNAStar, UK) as depicted in Table 1. However, 
only 4 pairs of primers (H41F1R1, S6F1R1, P1F2R2 and 
P1F2R1TX) derived from 4 DNA sequenced inserts (H41, 
S6, P1a and P1b) were designed (Figure 2).  
Specie-specificity was demonstrated by the primers 
P1F2R2 (Ta=66°C, 35 cycles) and P1F1R1TX-PCRs (Ta 
= 66°C, 35 cycles),  which  actually  were  specific  to  the  









GTTTCGCTCCCAGTTGATGTGGGTTAAAACAGATTGTTTTATCATCCCTCAAATTAAACA    60 











































































Figure 2. Olygonucleotide primers’ sequences for RAPD-PCR (Panels A TO C): Panel A, H41 plasmid 
(primers: F1 and R1); panel B, S6 plasmid (primers: F1 and R1) S6F1R1; panel C: P1a andP1b 
plasmids (primers F2 + R2, and F2 + R1TX, respectively) P1F2R2/P1F2R1TX. 




Table 1. Some chemical and physical properties of the experimental soils before sowing. 
 
Soil property  
Soil depth 
0 to 30 cm 30 to 60 cm 
pH (1:2 soil: water)  7.25 10.45 
Organic matter g kg–1  18 6.65 
CaCO3 g kg–1  150 137.28 
Total N g kg–1  0.78 0.28 
Available P mg kg–1  9.3 3.28 
    
Cation exchangeable capacity cmolc kg–1   32.0 27.5 
    
Exchangeable cations, cmolc kg–1 
 
Ca+2 19.8 20.09 
Mg+2 4.5 3.04 
K+1 2.7 1.33 
Na+1 0.15 0.10 
    
Microelements, mg kg–1 Fe+2 3.36 1.32 
Mn+2 1.74 1.17 
Zn+2 1.75 1.14 
Cu+2 0.78 0.69 
B 0.16 0.08 
    
Electric conductivity dS m–1  1.44 1.05 
    
Soil particle size distribution Clay % 32.6 27.5 
Silt % 42.3 40.4 
Sand % 25.1 32.1 
    




extent that they could not amplify even DNA derived from 
isolates of the same genus (E. multilocularis) nor equine 
isolates of E. granulosus that is phylogenetically 
considered as very distinct strains (Not shown). Never-
theless, these results could not distinguish strains of E. 
granulosus but identify strain-specific DNA fragments. 
Results obtained from DNA sequences database show-
ed homologies to some important proteins/ molecules: 
Laminin-binding protein (from clone S6), which belongs to 
the family of multifunctional egmo proteins in E. 
granulosus and glutathione (GSH) transferase was 
transcribed from clone S3 (sheep origin) as shown in 
Table 2. 
The H41 recombinant DNA demonstrated 58% homo-
logy to sequence LV0233066 Taenia solium UNAM-
cd2_larva cDNA, mRNA sequence a parasite in the same 
family. While P1a clone exhibits 62% similarity with 
Caenor-habditis briggsae contig cb25.fpc2888 from 
assembly cb25.agp8, accession number EMBL: CAAC-
01000061.  
In the present study, the PCR products amplified by the 
primers P1F2R2 (Ta=66°C, 35 cycles) and P1F1R1TX-
PCRs (Ta = 66°C, 35 cycles) demonstrated to be specie-
specific, thus, were unable to amplifyDNA derived from 
isolates of the same genus (E. multilocularis) nor equine 
isolates of E. granulosus that is phylogenetically consi-
dered as very distinct strains (Mwambete, 2002). 
Nevertheless, these results could not distinguish strains 
of E. granulosus but identify strain-specific DNA frag-
ments that could be further explored and come up with 
molecules of clinical interests. Moreover, this could be 
employed as starting-point by other researchers who may 
utilize larger number of restriction enzymes and thus 
produce strain-specific DNA band profiles and thus, 
identifies the distinctive fragments thoroughly.  
Proper diagnosis for hydatidosis and identification of 
each strain is of paramount importance, because of the 
differences in the parasite development, epidemiological 
characteristics and control measures (Schantz et al., 
1995; Capuano et al., 2006).  The main reason is the 
high manifested genetic variability of the parasite, which 
has its impact on chemotherapy as well (Hossein and 
Islami, 1998). Similarly, sometimes differential diagnosis 
is required to rule out other parasitic infections that 
resemble echninococcosis (George et al., 2004). 
It is well known that reproducibility of  the  amplification  




Table 2. Effect of boron applications on soil microbial population and CO2-C production.  
 




Bacteria Fungi Actinomycetes CO2-C 
SP FP HP SP FP HP SP FP HP SP FP HP 
0-30 0 25.70 b 37.75 b 29.61 ab 36.16 b 57.03 b 46.77 b 16.99 b 22.25 b 16.65 b 6.48 b 9.94 ab 7.78 b 
 1 31.42 ab 42.00 ab 30.36 ab 42.75 ab 67.30 ab 53.26 ab 17.33 ab 25.19 ab 19.85 ab 7.79 ab 11.52 ab 8.40 ab 
 3 34.67 a 47.50 a 37.60 a 46.91 a 72.64 a 61.25 a 21.00 a 31.03 a 24.19 a 8.57 a 12.67 a 10.20 a 
 6 25.37 ab 47.00 a 24.80 b 40.48 ab 72.00 a 59.12 a 17.66 ab 26.95 ab 20.46 ab 7.33 ab 12.55 a 8.26 ab 
 9 13.34 b 30.40 c 16.90 c 25.44 c 43.63 c 35.68 c 11.66 c 14.71 c 11.43 c 4.96 c 7.70 b 4.94 c 
Ave.  26.10 b 40.93 a 27.85 b 38.35 c 62.52 a 51.22 b 16.93 b 24.03 a 18.52 b 7.03 b 10.88 a 7.92 b 
30-60 0 13.20 b 19.27 b 15.03 ab 52.10 b 76.29 b 59.67 b 25.93 b 42.39 b 33.19 b 2.71 b 4.15 b 3.42 b 
 1 14.36 a 23.56 a 16.81 ab 60.14 ab 89.12 ab 63.98 ab 32.09 a 49.65 ab 36.81 ab 3.12 a 5.05 a 4.02 ab 
 3 15.27 a 24.15 a 21.05 a 65.21 a 95.80 a 79.70 a 35.79 a 55.07 a 43.36 a 3.67 a 5.60 a 5.75 a 
 6 14.00 a 24.00 a 19.79 a 57.37 ab 95.00 a 64.38 ab 29.93 ab 54.50 a 38.03 ab 3.23 a 5.21 a 3.92 ab 
 9 8.34 c 14.57 c 11.23 b 39.02 c 59.54 c 39.36 c 18.89 c 32.02 c 21.29 c 2.45 b 3.29 b 2.74 c 
Ave.  13.03 c 21.11 a 16.78 b 54.77 c 83.15 a 61.42 b 28.52 c 46.73 a 34.54 b 3.04 c 4.66 a 3.97 b 
 




reactions largely depend on specificity of primers 
and nature of nucleotides employed (Duarte and 
Izquierdo, 1992). Therefore, PCR and currently, 
DNA sequencing have taken the lead in this 
arena. 
Likewise, DNA sequencing, preceded by RAPD-
PCR has been utilized in screening for proteins of 
pharma-cological or/and diagnostic interests, 
using various online programs namely ExPASy-
proteomics tool, which translate DNA sequences 
into proteins and functional websites for parasites 
genomes (Ivens et al., 2000). Thus, narrowing the 
screening for drug targets using genetic or 
molecular based approaches, now seem to be 
more appropriate than the traditional one which 
involve huge amounts of reagents/resources, time 
and person-nel. This proves to be useful, parti-
cularly E. granulosus, since its in vitro tests 
usually take long time, a minimum of 3 to 6 
months, as result of slow in vivo and in vitro deve-
lopment of the parasite. In addition to that, the 
three protective hydatid cyst layers create another 
problem, as consequence of drug-permeability 
barrier and intrinsic drug solubility hindrance 
(Kammerer and Schantz, 1984; Hossein and 
Eslami, 1998). 
Information obtained from the DNA databases 
regarding E. granulosus nucleotides homology to 
other organisms, may lead to discovery of 
common drug targets and thus, these other 
microorganisms might also be used as alternative 
experimental modules in searching for novel 
chemotherapeutic agents. Genetic variability of 
various organisms is a result of either acquired or 
intrinsic factors that are inevitable means for 
survival and adaptation to environmental changes 
and challenges, which unfortunately, occasionally 
become detrimental to human beings (Hartwell et 
al., 2000). Drugs resistance is one of these 
calamities that can be effectively monitored by 
molecular genetic surveillance, thus, coming up 
with both ideal diagnostic and chemotherapeutic 
measures. Understanding gene sequences is 
crucial step towards underlying the molecular 
mechanisms such as essential biological 
processes, transmission, pathogenesis and drug 
resistance as well as identification of new drug 
targets and vaccine design. Nevertheless, geno-
mes may not easily translate into a compre-
hensive recognition of gene and their roles in 
parasites biology (Ferdig and Su, 2000; Zhao and 
Hamilton, 2007). In that instance, complementary 
methods might be required to define relationship 





differences and their consequent functional effects.  
Results obtained from DNA sequences database show 
homologies to some important proteins/molecules that 
can be further explored and come up with potential drug 
targets like laminin-binding protein (from clone S6), which 
belongs to a family of multifunctional egmo proteins in E. 
granulosus, is associated with cell division and growth 
(Zhang et al., 1997). Laminin-receptor seems to be 
associated with invasive capacity and pathogenesis in 
bacteria and fungi (Narasimhan et al., 1994). From clone 
H35, elongation factor -1 (EF-1) was also uncovered. The 
parasite shows a high conservation of amino acids at the 
conserved position for EF-1 hand calcium-binding sites 
(Rodrigues et al., 1997). 
Glutathione (GSH) transferase was also transcribed 
from clone S3. Usually, the helminth GSH transferase is 
present as isoenzymes, although, does not elicit clear 
biochemical homology to any of the three mammalian 
GSH transferase families. The GSH have diverse 
functions including detoxification, binding a range of 
anthelminthics and lipid peroxidation (Brophy and Barrett, 
1990). On the other hand, H41 recombinant DNA with 
58% homology to sequence LV0233066 T. solium 
UNAM-cd2_larva cDNA, mRNA sequence, is a parasite 
in the same family that buttress the RAPD-PCR findings. 
P1a clone exhibits 62% similarity with C. briggsae contig 
cb25.fpc2888 from assembly cb25.agp8, accession 
number EMBL: CAAC01000061 (Gish and States, 1990).  
It is clear that RAPD-PCR and DNA sequencing cannot 
be routinely performed, because of not being cost-
effective; however, they may be used for monitoring drug 
efficacy and resistance. In the long-run, they are worth to 
be conducted.  However, if they are ignored, it may lead 
to utilization of chemotherapeutic agents on already 
resistant organisms, thus, incurring unnecessary expen-
ses. It is therefore suggested that, RAPD-PCR, DNA 
sequencing and other similar approaches need to be 
periodically employed for monitoring genetic-mole-cular 
variability, screening and designing novel molecules for 
targeted therapy on the altered/ mutated drug receptors. 
Finally, better understanding of pathogens, patho-
genesis and diagnosis may contribute to appropriate and 
timely therapy (Kiresi et al., 2003; Masroor et al., 2010). 
In order to attain this, integrated techniques and appro-
aches in fighting this parasitosis are inevitable. Such 
strategy can certainly improve our health care systems 
and thus, save patients’ lives and untimely deaths. In this 
case, not only human can benefit from the advance in 
science and technology by increased income and pro-
ductivity. Consequently, effective exploration and 
validation of these targets may definitely lead to dis-
covery of therapeutic targets against parasitic helminthic 
and microbial infections. Notwithstanding that the present 
study indicates partial success on attaining distinctive 
strain-specific DNA sequences, the resultants PCR 
products were not strain-discriminatory. It is speculated 
that incorporation of more restriction  endonucleases  and  




well-adjusted reaction conditions, a differential PCR-
RFLP can be obtained. Similarly, an increase of HC 
sample size from distinct regions may lead to acquisition 
of diverse DNA molecules hence, exploring further on 
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